Intranasal deferoxamine can improve memory in healthy C57 mice, suggesting a partially non‐disease‐specific pathway of functional neurologic improvement

INTRODUCTION: Intranasal deferoxamine (IN DFO) has been shown to decrease memory loss and have beneficial impacts across several models of neurologic disease and injury, including rodent models of Alzheimer's and Parkinson's disease. METHODS: In order to assess the mechanism of DFO, determ...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Brain Behav
Главные авторы: Fine, Jared M., Kosyakovsky, Jacob, Baillargeon, Amanda M., Tokarev, Julian V., Cooner, Jacob M., Svitak, Aleta L., Faltesek, Katherine A., Frey, William H., Hanson, Leah R.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066355/
https://ncbi.nlm.nih.gov/pubmed/31960628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/brb3.1536
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы